Borrelidin, an antibiotic from Streptomyces rochei, was found to be an angiogenesis inhibitor in a rat aorta matrix culture model which forms capillary vessels in vitro. Borrelidin strongly inhibited capillary tube formation with a 50%-inhibitory concentration value of 0.8 nM, and decreased the number of capillary tubes within 24 hours when added after maturation of tube formation. Borrelidin remarkably disrupted capillary tubes in a dose-dependent manner, by inducing apoptosis of the tube-forming cells.
Angiogenesis, the formation of new blood vessel capillaries, plays an important role in a variety of pathological conditions, such as tumor growth, diabetic retinopathy, rheumatoid arthritis and atherosclerosisX). Furthermore, the growth of solid tumors to beyond microscopic size, 1~2mmin diameter, depends on the development of an adequate blood supply through angiogenesis20. On the basis that an anti-angiogenesis strategy might represent a new therapeutic approach for the treatment of solid tumors, several angiogenesis inhibitors are currently undergoing clinical trials3~6).
Angiogenesis is a complex biological process whose regulatory mechanismsare incompletely understood: it is influenced not only by growth factors such as vascular endothelial growth factor (VEGF), basic flbroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) secreted by tumor or mesenchymal cells7), but also by extracellular matrix componentsand proteases8).
Although it is possible to investigate proliferation, migration and proteolytic activity using endothelial cells isolated from the vascular wall, those cultures represent only a partial reconstruction of in vivo angiogenesis. In contrast, fragments of rat thoracic aorta form microvessels (capillary tubes) in 7 days in a serum-free matrix culture within type I collagen gel9 carefully removed and rinsed with Hank's solution. The aortas were cut into small fragments (2x2mm) and transferred to wells of a 24-wells culture plate containing collagen gel (0.5 ml). After collagen gelation, MCDB131 medium (0.5 ml) was added on top of the gel in the wells.
The mediumwas changed to extract-or borrelidincontaining medium on day 2 and on day 5. At 7 days after the beginning of the experiment, (day 8), microvessels were counted under a light microscope. For assay of tube disruption, 1 ml of medium containing borrelidin was added to the gels. Testing was conducted using four cultures per dose and results were confirmed by repeated experiments.
Cell Growth Assay HUVEC (1 x 103 cells) were cultured with E-GM medium containing 2% fetal calf serum (FCS) in 96-well plates. At 3 days after addition of borrelidin, the ratios of surviving cells were measured by means of the MTT assay. Other cell lines were cultured with RPMI1640 media containing 10% FCS. The cell toxicity assay was carried out as follows: 1 x 104 HUVECper well (6-well plate) were cultured with borrelidin. After 24 hours, cells were recoved from the plate by trypsin-EDTA treatment and the cell numbers were counted under a microscope.
Macromolecular Biosynthesis Assay HUVEC(1 x 104 cells) were cultured with 500/d of E-GMmedium containing 2% PCS in a 24-well plate. After 1 day, the culture mediumwas changed to fresh medium containing borrelidin. 3H-Labeled thymidine, uridirie or leucine was added at 1 hour after borrelidin treatment and the cells were cultured for 1 hour, then washed with PBS followed by 5% trichloroacetic acid, and solubilized with 0.25m NaOH.The amount of radioisotope incorporated into the cells was measured with a liquid scintillation counter.
Threonyl tRNA Synthetase Assay Threonyl tRNAsynthetase was prepared from KBcell AUG. 1997 lysate, and the assay was performed by the method described previously1 7).
TUNELMethod
Labeling of nuclear DNAwas performed by the method described previously18). Gels were fixed with 4% paraformaldehyde for 2 hours at 4°C, then rinsed with phosphate-buffered saline (PBS) containing 0, 1 % Tween 20, and endogenous peroxidase was inactivated by soaking them with 5% H2O2for 5 hours. The gels were then rinsed and reacted with TdT and biotinylated dUTP for 30 minutes. Staining was performed with streptoavidin-peroxidase.
Results
Amongseveral thousand strains of actinomyces, broth of Mer-N7167 strain, a strain of Streptomyces rochei,
showed a potent inhibitory activity in the RATFmodel at the concentration of 0.00065%. Weisolated the active product by Shephadex LH-20 column chromatography followed by silica gel column chromatography and identified it as borrelidin11'16) on the basis ofNMR, IR and mass spectrometry (Fig. 1) . As shown in Fig. 2 , borrelidin strongly inhibited the tube formation of rat aorta; the IC50 value was 0.4 ng/ml (0.8 nM). The anti-proliferative activity towards human umbilical vein endothelial cells (HUVEC) was 15-fold weaker than the anti-angiogenesis activity in the same medium (IC5O = 6 ng/ml). Anti-proliferative activities of borrelidin towards various other cell lines were examined, and the results (Table 1) suggest that this compound has a general activity towards various cell types.
In the aortic angiogenesis experiment, migrating cells appeared after 3~5 days, followed by microvascular sprouts, and vascular growth continued for 1 to 2 weeks after the beginning of the experiment. To study the mechanism of action, we treated aortic collagen gel culture with borrelidin (2ng/ml) over three different periods, days 2~4, 4~6 and 6-8, and counted the number of tubes on day 8. Borrelidin showed similar effects in each case, and day 6~8 treatment actually decreased the number of capillary tubes (Fig. 3) . To investigate the action of borrelidin on capillary tubes in detail, borrelidin was added to aortic gel culture when the aorta had formed 20-30 capillary tubes (on day 6). Within 24 hours borrelidin disrupted the capillary tubes in a dose-dependent manner, and the tubes completely disappeared at the dose of 3ng/ml; the IC50 was about 1ng/ml (Fig. 4) . During this time, the cell death of endothelial cells composing the tubes was observed under a microscope (Fig. 5-B, C) . Other migrating cells, perhaps smooth muscle cells19), were unaffected ( Fig.   5-C) , indicating that borrelidin selectively acted toward endothelial cells. In order to clarify whether or not the mechanism of cell death induced by borrelidin involves apoptosis, we applied TUNELmethod18*, which detects nicked DNA. At 4 hours after treatment, the gels containing capillary tubes and migrating cells were clearly stained (data not shown). Therefore, it seems that (Fig. 6) , suggesting that these activities may account for the anti-proliferative activity. Borrelidin also showed potent inhibition in mouse dorsal air sac model20), a model of tumor-angiogenesis, at the dose of 1.8 mg/kg by intraperitoneal injection (in preparation), confirming that borrelidin is a potent angiogenesis inhibitor. HUVEC were plated into 24-well plates at a density of 1.3 x lO4cells/well.
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